BridgeMD
New treatment option for Opioid-use Disorder
Official title Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
ClinicalTrials.gov ID: NCT04927143
What this study is testing
- What it's testing
- Combatting the rise of the opioid epidemic is a central challenge of U.S. health care policy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age at least 18 years old;
- Meet DSM-5 OUD, CoUD, or MUD criteria as evidenced by an OUD CPT code F11\ (opioid related disorders), a CoUD CPT code F14\ (cocaine related...
- Have access to a smartphone (iOS or Android) with data plan and willing to download DynamiCare app;
- Have an email and can access it from their smartphone;
- Are in residential, day (PHP), partial day (IOP), or outpatient (OP) AODA treatment;
You likely can't join if
- Have evidence of active (non-substance related) psychosis that might impair participation as determined by the PI.
- Has significant cognitive impairment that might confound participation as determined by the PI or are so significantly cognitively impaired that they...
See the full eligibility criteria
- Age at least 18 years old;
- Meet DSM-5 OUD, CoUD, or MUD criteria as evidenced by an OUD CPT code F11\ (opioid related disorders), a CoUD CPT code F14\ (cocaine related disorders), a MUD CPT code F15.1/F15.2 or other clinical notes indicating...
- Have access to a smartphone (iOS or Android) with data plan and willing to download DynamiCare app;
- Have an email and can access it from their smartphone;
- Are in residential, day (PHP), partial day (IOP), or outpatient (OP) AODA treatment;
- Are likely to be helped by contingency management because at least ONE of the following conditions is true:
- Were first enrolled in residential, PHP, or IOP substance use treatment no longer than 2 treatment weeks (14 days/encounters of treatment) prior to providing informed consent.
- Used non-medical opioids, cocaine, and/or methamphetamine within the last 21 days.
- Understands English.
- Have evidence of active (non-substance related) psychosis that might impair participation as determined by the PI.
- Has significant cognitive impairment that might confound participation as determined by the PI or are so significantly cognitively impaired that they have a legal guardian.
The study team makes the final eligibility decision.
Where it's taking place
- Oconomowoc, Wisconsin, United States
- Wauwatosa, Wisconsin, United States
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oconomowoc, Wisconsin, United States; Wauwatosa, Wisconsin, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.